Novamind

Numinus Wellness Announces Q3 Results

Novamind To Offer Virtual Mental Health Therapy Sessions

Novamind Begins Clinical Trial Of Psilocybin For Depression

Sponsored

Novamind To Offer Virtual Mental Health Therapy Sessions

Novamind Begins Clinical Trial Of Psilocybin For Depression

Sponsored

Novamind Opens Addiction Clinic In Utah, Establishing Substance Use Disorder Program

Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders

Novamind Opens Addiction Clinic In Utah, Establishing Substance Use Disorder Program

Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders

4 Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference

Psyched: Novamind Partners With Merck, Atai Expands To Japan, Australia Funds Psychedelics Research

Novamind Recent News

4 Psychedelics Experts On Adoption In Mainstream Medicine: 'A Mental Health Revolution'

The use of psychedelics for medical treatment is achieving a new sense of gravitas, according to the guest panelists at Benzinga's latest Cannabis Capital Conference.

What Will The Psychedelics Space Look Like In 2021? Experts Weigh In

In 2020, psychedelics took the world by storm. Over two dozen companies in the sector became publicly listed.

Psyched: NeonMind, Novamind Go Public; MAPS And Field Trip Study MDMA, Psychedelics Center Launches In NYC

NeonMind Goes Public Psychedelics biotech company NeonMind debuted on the Canadian Securities Exchange (CSE) Monday under the symbol ‘NEON.’

Exclusive: Novamind CEO On Going Public: 'We're Focused On Treating People Today'

Novamind became the latest psychedelics company to go public through a reverse take-over with Hinterland Metals Inc. The company debuted in the Canadian Securities Exchange on Tuesday under the symbol "NM."

Psyched: The First Psychedelics ETF, Beckley Raises $19M, 3 Companies Go Public

The Psychedelics Sector Might Soon Get Its First ETF Financial services company Horizons ETFs Management filed documents with the Ontario Securities Commission for a psychedelics ETF, which is expected to go live on Jan. 15.

'Psyched': Atai Buys Kures, Beckley Psytech Raises $3.7M, Mydecine Acquires NeuroPharma

PSYCHED is now weekly! As the psychedelics industry grows, so does the need for news. For this reason, our column covering the most important developments in medicinal psychedelics is now a weekly feature.